Get in the KNOW
on LA Startups & Tech
X
Photo by Szabo Viktor on Unsplash
Creator Startup Jellysmack Buys YouTube Analytics Firm AMA Digital
Christian Hetrick
Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.
Creator economy startup Jellysmack has acquired AMA Digital, a Chicago-based YouTube analytics company, for an undisclosed amount.
Jellysmack said Tuesday that it will use AMA’s data analytics to boost its creator program, which helps roughly 500 content creators grow their audiences and revenues. The company, which has more than 120 employees in Los Angeles and partners with over 80 L.A.-based creators, uses A.I. technology, proprietary data and video editing tools to optimize and launch videos on YouTube, TikTok, Snapchat and other platforms.
“We believe Jellysmack offers the best tech stack available in the creator economy, and the acquisition of AMA will further strengthen our core product to better serve our creator partners,” Michael Philippe, Jellysmack’s co-founder and co-CEO, said in a statement.
Founded in 2019 by Mateo Price, Chicago-based AMA claims to use proprietary data and technology to help YouTubers increase their revenue and viewership. The company says it has generated millions of dollars in incremental revenue for its creators—including popular YouTubers Jesser, Ali Abdaal and Dylan Lemay, among others—who collectively have 60 million subscribers. As part of the deal, Price will join Jellysmack as director of YouTube development.
In addition to enhancing its creator program, Jellysmack said AMA’s platform will help with its catalog licensing business, as well. In January, the company announced it would spend $500 million to license the monetization rights to YouTube creators’ back catalogs. The business of YouTube catalogs as lucrative assets has quickly gained ground, with L.A.-based Spotter also offering upfront payments to license YouTubers’ libraries.
Founded in 2016, New York-based Jellysmack’s most recent funding round, announced in May 2021, was led by Japanese investment giant SoftBank. While the startup did not disclose the size of the investment, PitchBook data indicates that Jellysmack raised $950 million at a $3 billion valuation. (A company spokesperson would only disclose the startup’s valuation as over $1 billion.) Jellysmack claims its managed content generates 10 billion global monthly video views and reaches 125 million unique U.S. users. Its roster of creators includes YouTubers like MrBeast, PewDiePie and Karina Garcia.
The AMA deal is Jellysmack’s second-ever acquisition, following the November purchase of A.I. video editing technology company Kamua.
From Your Site Articles
- Spotter Raises $200 Million To License YouTubers' Old Videos - dot ... ›
- Jellysmack 'Clickable' AI Startup Joins the Unicorn Club - dot.LA ›
- Jellysmack Welcomes TikTokers to Creator Program - dot.LA ›
- Jellysmack Welcomes TikTokers to Its Creator Program - dot.LA ›
- Jellysmack Launches Jellysmash Creator Production Studio - dot.LA ›
Related Articles Around the Web
Christian Hetrick
Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.
A Google for Biotech: Sci Find Launches a Tool to Connect Researchers and Funders
07:10 AM | February 05, 2021
Photo by National Cancer Institute on Unsplash
A former Facebook machine learning analyst is behind Sci Find's new Google-like search engine for bioscience companies. The service launches Monday, aiming to eliminate the often-tedious task researchers must face to find labs that can help them test different products or drugs.
The startup used AI to cull thousands of publicly available research abstracts from the National Institute of Health and is now gathering proprietary documents to build its free search engine. It provides results on researchers' contact information, patents and expertise.
"The scientific part of science is very innovative and groundbreaking," said Sci Find co-founder and genomics expert Guy Rohkin. "But a lot of the communication channels and the way that the information is disseminated is kind of traditional and disjointed."
"What we tried to do on our platform was use AI so that your search queries are more accurate and there's more utility than if you were to go use Google," said Stefani Robnett, former machine learning analyst at Facebook. She founded Sci Find with Rohkin in 2019.
The project was inspired by Rohkin's struggle as an outsourcing provider for a genomics company. His work there required him to sift through pages of research reports in order to find clients who specialized in an extremely obscure niche within life sciences the company was trying to make waves in.
"You have to really hit the exact thing that they want," Rohkin said. "Someone who's doing next-gen sequencing is highly, highly specialized in it, so you can only sell the products and services in that field."
Sci Find allows partners to connect and chat within the platform. That's big for biotech startups, many of which seek to outsource research tasks or large scale trials to more established companies.
Outsourcing in biopharma became increasingly common after the "blockbuster drug" era around the 2008 recession, when big companies began to offload the cost of manufacturing facilities and in-house research and development teams. It created growth among small labs and researchers who operate independently, sometimes with the help of venture capital. When those labs start developing and testing new technologies, they turn to larger companies.
According to a white paper by Provident Healthcare Partners, the majority of small biopharma companies developing drugs rely on outsourcing to develop the active ingredients.
Among its beta testers is California Nanotechnologies, a Cerritos-based lab that provides research and development and access to cryogenic services. Microbiologics, another lab specializing in antimicrobials, is also testing the product. Both hope that the new search engine will connect their lab with new customers.
Sci Find raised $800,000 in a family-and-friends pre-seed funding round in May 2020 and is now raising its seed funding.
From Your Site Articles
- Can LA County's New Fund Get Local Biotech Startups to Stick ... ›
- Westlake Village BioPartners Aims to Catalyze Biotech in LA - dot.LA ›
- Good Growth Capital's Z Holly on Biotech and Education - dot.LA ›
- First Look Features Life Science Startups from SoCal Schools - dot.LA ›
Related Articles Around the Web
Read moreShow less
Keerthi Vedantam
Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.
https://twitter.com/KeerthiVedantam
keerthi@dot.la
Momentum in Motion: IPOs, Partnerships, and Innovation
01:58 PM | December 13, 2024
🔦 Spotlight
Happy Friday, Los Angeles!
Last week, we dove into some of the major moves shaping LA’s tech scene, from ServiceTitan’s IPO ambitions to Anduril’s AI advancements. This week, the story continues with new milestones and updates that reveal how quickly the landscape is evolving. Here’s what’s happening now:
ServiceTitan’s IPO: A Fintech Spark
ServiceTitan’s initial public offering has proven to be a resounding success.The Glendale-based company priced its IPO at $71 per share, significantly above the anticipated range of $52 to $57. On its first trading day, shares opened at $101 and closed at $101.20, marking a 43% increase and valuing the company at nearly $9 billion. This impressive debut underscores ServiceTitan’s growing influence in the trades software space and signals a potential trend for other fintech leaders to watch closely. Read more about ServiceTitan's IPO success here.
Anduril Industries: Expanding the Horizon
We recently covered Anduril’s groundbreaking partnership with OpenAI, emphasizing the growing role of AI in defense. This week, Anduril continues to make headlines with new developments and collaborations that underscore its commitment to reshaping national security and autonomous technology:
- Partnership with Palantir:Anduril and Palantir are teaming up to accelerate AI capabilities in defense. Together, they aim to integrate Palantir’s advanced data analytics with Anduril’s autonomous systems, creating a platform capable of delivering actionable intelligence in real time. This partnership is expected to enhance battlefield decision-making, reduce operational risks, and maintain U.S. leadership in defense technologies. Read more about the partnership here.
- Dive XL Autonomous Submarine: Anduril’s Dive XL submarine is setting new standards for maritime autonomy. This long-endurance unmanned vehicle can operate in harsh underwater environments for extended periods, providing capabilities for intelligence gathering, surveillance, and reconnaissance. With its modular design, Dive XL supports a range of payloads, making it a versatile asset for maritime security. Learn more about Dive XL here.
- Archer VTOL Aircraft Partnership: Anduril’s collaboration with Archer Aviation is pushing the boundaries of autonomous flight technology. This partnership leverages Archer’s expertise in vertical takeoff and landing (VTOL) aircraft to complement Anduril’s advanced defense systems. By integrating Anduril’s cutting-edge AI capabilities with Archer’s innovative designs, the companies aim to create next-generation solutions for tactical military operations. This partnership reflects a shared commitment to innovation and positions both companies as leaders in reshaping the future of aerial defense. Details about the partnership are available here.
Writers Guild Challenges AI in Hollywood
The Writers Guild of America (WGA) continues its efforts to address the growing influence of AI in entertainment. In recent negotiations, the Guild has pushed for clear boundaries on the use of generative AI in scriptwriting, emphasizing the need to protect writers’ rights and creative integrity. As the industry grapples with the implications of this technology, the WGA’s stance highlights an ongoing effort to balance innovation with fairness in Hollywood. Read more about the Guild’s actions here.
Our thoughts are with the residents of Malibu as they face wildfires fueled by Santa Ana winds, which have displaced many and disrupted communities, including Pepperdine University. For resources during emergencies, explore ourguide to the top tech apps for natural disasters, highlighting tools to support preparation and safety.
From tech breakthroughs to creative industry challenges, the region’s innovation engine shows no signs of slowing. As 2024 approaches, one thing is clear: the momentum isn’t slowing down.
✨ Featured Event ✨
2024 PledgeLA Catalyst Awards
Image Source: Instagram: PledgeLA
Catalyst Awards to Honor Inspiring Entrepreneurs and Emerging Managers in Venture Capital, Catalysts Improving Access to Capital Across Los Angeles
PRINCIPALS AND HOSTS: The Annenberg Foundation and PledgeLA, the initiative launched in 2018 by the Annenberg Foundation and the City of Los Angeles to promote equity and increase access to capital for L.A.-based startups and investors from underrepresented backgrounds.
WHEN: Wednesday, December 18, 2024 at 5:30 p.m. PST.
WHERE: Register to See Address Los Angeles, California
🤝 Venture Deals
LA Venture Funds
- Alpha Edison led a $27M Series A funding round, joined by Acre Venture Partners, ReMY, among others, for One Bio, a UC Davis spinoff based in California that is developing biotech solutions to bridge the dietary fiber gap, with plans to scale production and expand its product offerings. - learn more
- Gideon Strategic Partners participated in a $110M Series C funding round for Capstan Medical, a Santa Cruz-based company developing robotics technology for heart disease treatment, with the funds aimed at advancing clinical trials and preparing for commercialization. - learn more
- Alexandria Venture Investments participated in a $75M financing round to support the formation of nChroma Bio, a new biotechnology company created through the merger of Chroma Medicine and Nvelop Therapeutics, focused on advancing gene-editing therapies for genetic blood disorders. - learn more
- Riot Ventures led a $10.1M Seed funding round for Deterrence, a company developing automated solutions for energetics production, including explosives and propellants, with participation from Impatient Ventures and others, to scale its technology, improve manufacturing efficiency, and meet growing industry demands. - learn more
- Chapter One Ventures participated in a $12M Series A funding round for Hyperbolic, a San Francisco-based AI company specializing in predictive analytics for supply chain optimization, with plans to use the funds to enhance its technology platform and expand its team. - learn more
- Blue Bear Capital participated in a $35M Series C financing round for Raptor Maps, a Boston-based company that provides software solutions for solar asset management. The funds will be used to enhance their AI-driven platform, expand global operations, and support the growing needs of the renewable energy industry. - learn more
- Behind Genius Ventures and Night Ventures, among others, participated in a $3M Pre-Seed funding round for Moldco, a Boston-based company providing digital, evidence-based care, treatments, and lab testing to help individuals reclaim their health from mold toxicity, with plans to use the funds to expand operations nationwide in 2025. - learn more,
- Regeneration.VC co-led a €8M Series A funding round for Orbisk, a Netherlands-based company that develops AI-powered food waste monitoring systems for the hospitality industry, with plans to use the funds to expand internationally and enhance their technology platform - learn more
- Mucker Capital participated in a $17M Series A funding round for Ask Sage, an Arlington, VA-based company offering a generative AI platform for government and commercial sectors, with plans to use the funds to expand its AI capabilities, drive growth, and increase its workforce. - learn more
- Magnify Ventures participated in a $8M Series A funding round for MiSalud Health, digital health platform offering affordable, same-day bilingual telehealth consultations in Spanish and English to better serve Hispanic communities in the U.S. and Mexico. With a focus on improving access for Spanish-speaking individuals, the company aims to address the growing demand for culturally and linguistically appropriate healthcare solutions as the Hispanic population continues to expand rapidly in the U.S.. - learn more
LA Exits
- Elios Vision, a company specializing in innovative glaucoma treatment technologies, has been acquired by Bausch + Lomb to strengthen its portfolio in addressing the needs of glaucoma patients. The acquisition brings Elios Vision's cutting-edge solutions into Bausch + Lomb's comprehensive eye health offerings, expanding its capabilities to provide advanced care for this critical condition. - learn more
- OceanX, a provider of subscription-focused fulfillment and logistics solutions, has been acquired by Cart.com to enhance its end-to-end e-commerce platform and expand its capabilities in subscription management and order fulfillment. - learn more
Read moreShow less
RELATEDTRENDING
LA TECH JOBS